Table 7.
Multidrug resistance patterns of Gram-negative bacteria isolated from patients with infections.
| Microorganism | Number of antibiotics | Antibiotic resistant isolates No (%) |
Multidrug resistance patterns |
|---|---|---|---|
| Escherichia coli (No = 659) | 6 | 45 (6.8) | SXT, TE, IMP, GM, CHL, COL |
| 5 | 35 (5.3) | SXT, CRO, CIP, GM, AMK | |
| 4 | 58 (8.8) | SXT, TE, CIP, GM | |
| 4 | 36 (5.5) | SXT, TE, CHL, CIP | |
| 3 | 62 (9.4) | SXT, TE, CHL | |
| 3 | 66 (10) | SXT, TE, IMP | |
| 3 | 54 (8.2) | SXT, CRO, CIP | |
|
| |||
| Klebsiella spp. (No = 248) | 5 | 3 (1.2) | SXT. TE, CIP, GM, COL |
| 4 | 47 (18.9) | CRO, CIP, GM, AMK | |
| 3 | 33 (13.3) | SXT, TE, IMP | |
| 3 | 36 (14.5) | SXT, TE, CHL | |
| 3 | 26 (10.5) | SXT, CRO, CIP | |
|
| |||
| Enterobacter spp. (No = 62) | 4 | 4 (6.4) | CRO, CIP, GM, AMK |
| 3 | 6 (9.7) | SXT, TE, CRO | |
| 3 | 7 (11.3) | SXT, TE, IMP | |
| 3 | 6 (9.7) | SXT, TE, CHL | |
|
| |||
| P. aeruginosa (No = 142) | 4 | 14 (9.9) | IMP, CIP, GM, AMK |
|
| |||
| Acinetobacter spp. (No = 185) | 7 | 129 (69.7) | SXT, TE, IMP, CRO, CIP, GM, AMK |
| 6 | 6 (3.2) | SXT, TE, IMP, CIP, GM, AMK | |
| 5 | 31 (16.7) | SXT, IMP, CIP, GM, AMK | |
| 4 | 6 (3.2) | IMP, CIP, GM, AMK | |
| 4 | 2 (1.1) | SXT, IMP, GM, AMK | |
| 4 | 1 (0.5) | SXT, CIP, GM, AMK | |
| 4 | 2 (1.1) | SXT, IMP, CIP, AMK | |
| 3 | 8 (4.3) | SXT, IMP, CIP | |
|
| |||
| Proteus spp. (No = 63) | 3 | 5 (7.9) | SXT, CHL, CIP |
SXT: Co-Trimoxazole, TE: Tetracycline, IMP: Imipenem, GM: Gentamicin, CHL: Chloramphenicol, COL: Colistin, CRO: Ceftriaxone, CIP: Ciprofloxacin, and AMK: Amikacin.